Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15485848rdf:typepubmed:Citationlld:pubmed
pubmed-article:15485848lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0084024lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0035298lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0086376lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C1823153lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C2349976lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C1552644lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0205266lld:lifeskim
pubmed-article:15485848lifeskim:mentionsumls-concept:C0596448lld:lifeskim
pubmed-article:15485848pubmed:issue52lld:pubmed
pubmed-article:15485848pubmed:dateCreated2004-12-21lld:pubmed
pubmed-article:15485848pubmed:abstractTextPhosducin (Pdc) is a G protein beta gamma dimer (G beta gamma) binding protein, highly expressed in retinal photoreceptor and pineal cells, yet whose physiological role remains elusive. Light controls the phosphorylation of Pdc in a cAMP and Ca(2+)-dependent manner, and phosphorylation in turn regulates the binding of Pdc to G(t)beta gamma or 14-3-3 proteins in vitro. To directly examine the phosphorylation of Pdc in intact retina, we prepared antibodies specific to the three principal phosphorylation sites (Ser-54, Ser-73, and Ser-106) and measured the kinetics of phosphorylation/dephosphorylation during light/dark adaptation and the subsequent effects on G(t)beta gamma binding. Ser-54 phosphorylation increased slowly (t((1/2)) approximately 90 min) during dark adaptation to approximately 70% phosphorylated and decreased rapidly (t((1/2)) approximately 2 min) during light adaptation to less than 20% phosphorylated. Ser-73 phosphorylation increased much faster during dark adaptation (t((1/2)) approximately 3 min) to approximately 50% phosphorylated and decreased more slowly during light adaptation (t((1/2)) approximately 9 min) to less than 20% phosphorylated. The Ca(2+) chelator BAPTA-AM blocked Ser-54 phosphorylation during dark adaptation but had no effect on Ser-73 phosphorylation. In contrast, Ser-106 was not phosphorylated in either the light or dark. Importantly, G beta gamma binding to Pdc was enhanced by Ca(2+) chelation and the binding kinetics closely paralleled those of Ser-54 dephosphorylation, indicating that Ser-54 phosphorylation controls G(t)beta gamma binding in vivo. These results suggest a pivotal role of Ser-54 and Ser-73 phosphorylation in determining the interactions of Pdc with its binding partners, G(t)beta gamma and 14-3-3 protein, which may regulate the light-dependent translocation of the photoreceptor G protein.lld:pubmed
pubmed-article:15485848pubmed:languageenglld:pubmed
pubmed-article:15485848pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:citationSubsetIMlld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15485848pubmed:statusMEDLINElld:pubmed
pubmed-article:15485848pubmed:monthDeclld:pubmed
pubmed-article:15485848pubmed:issn0021-9258lld:pubmed
pubmed-article:15485848pubmed:authorpubmed-author:ThulinCraig...lld:pubmed
pubmed-article:15485848pubmed:authorpubmed-author:WillardsonBar...lld:pubmed
pubmed-article:15485848pubmed:authorpubmed-author:LeeBruce YBYlld:pubmed
pubmed-article:15485848pubmed:issnTypePrintlld:pubmed
pubmed-article:15485848pubmed:day24lld:pubmed
pubmed-article:15485848pubmed:volume279lld:pubmed
pubmed-article:15485848pubmed:ownerNLMlld:pubmed
pubmed-article:15485848pubmed:authorsCompleteYlld:pubmed
pubmed-article:15485848pubmed:pagination54008-17lld:pubmed
pubmed-article:15485848pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:meshHeadingpubmed-meshheading:15485848...lld:pubmed
pubmed-article:15485848pubmed:year2004lld:pubmed
pubmed-article:15485848pubmed:articleTitleSite-specific phosphorylation of phosducin in intact retina. Dynamics of phosphorylation and effects on G protein beta gamma dimer binding.lld:pubmed
pubmed-article:15485848pubmed:affiliationDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602, USA.lld:pubmed
pubmed-article:15485848pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:287007entrezgene:pubmedpubmed-article:15485848lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15485848lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15485848lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15485848lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15485848lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15485848lld:pubmed